SEC Filing Details
Document Details
Form
Filing Date
Jan 23, 2023
Document Date
Jan 20, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Urogen Pharma Inc.
Issuer
UroGen Pharma Ltd.
Filer
Schoenberg Mark